Drug Utilization Review of Anti-Diabetic Medications and Therapeutic outcome in type 2 Diabetes in a Tertiary Hospital in Northern Nigeria
Main Article Content
Abstract
Background: Attainment of therapeutic goals in Type 2 Diabetes Mellitus (T2DM) necessitates the rational use of drugs, given the wide options available and the presence of co-morbid diseases.
Objectives: To evaluate the drug utilization parameters and short- term outcome of pharmacotherapy in T2DM patients attending a tertiary hospital in Northern Nigeria.
Methods: Data was obtained from the folders of outpatients that attended clinic between June 2010 and June 2011 using a structured proforma and analyzed with descriptive statistics and chi square.
Results: The mean number of drugs per prescription was 5.29 ± 0.09, while drugs prescribed from the Essential Drug List were 48.1%. Generic, proprietary prescriptions and fixed dose combinations were 66.72%, 33.27% and 5.91% respectively. The number of encounters with an injection and an antibiotic, were 18(16.38%) and 19 (17.27%) respectively. There was a therapy change in 71.9%, whereas 29.1% had a same drug same dose prescription. Metformin-glibenclamide therapy was most utilized (53.27%). There was no statistically significant difference between the outcome of therapy in patients with initial poor glycaemic control and those with optimum glycaemic control. Hypertension was the commonest co-morbid disease (86.1%) with angiotensin converting enzyme inhibitors being most prescribed (72.52%) antihypertensive drugs.
Conclusion: Utilization of anti-diabetic agents was rational. However outcome of therapy in patients studied could still be improved by close monitoring of patient factors that may affect efficacy and encouraging patients' adherence.
Downloads
Article Details
References
Gill GV, Mbanya JC, Ramaiya K L, Tesfaye S (2009). A Sub-Saharan African perspective of Diabetes. Diabetologia 52:816.
Godfrey R, Julien M (2005). Urbanisation and Health. Clin Med 5:137-141.
Shaw JE, Sicree RA, Zimmet PZ (2010). Global Estimates of the Prevalence of Diabetes for 2010 and 2030. Diabetes Research and Clinical Practice (87): 4-14.
Azevedo M, and Alla S (2008). Diabetes in SubSaharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia. International Journal of Diabetes in Developing Countries. 28(4): 101-108.
World Health Organization. Diabetes Fact Sheet. (2011);Availableat:http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed March 15 2011.
Ogbera AO, Chinenye S, Onyekwere A, Fasanmade O (2007) Prognostic indices of diabetes mortality. Ethnicity and Disease. (17): 721-725.
Idemyor V (2010). Diabetes in Sub-Saharan Africa: Health Care Perspectives, Challenges, and the Economic Burden of Disease. Journal of the National Medical Association 102(7): 650-653.
Sachdeva P D and Patel BG (2010). Drug Utilization Studies- Scope and Future Perspectives. International Journal on Pharmaceutical and Biological Research 1(1): 11-17.
World Health Organization (1993) Action Programme on Essential Drugs. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva,World Health Organization, (WHO/DAP/93.1).
Adibe MO, Aguwa CN, Ukwe CV, Okonta JM, Udeogaranya PO (2009). Outpatient Utilization of AntiDiabetic Drugs In The South Eastern Nigeria. International Journal of Drug Development and Research 1 (1):| 27
Hassan Y, Mathialagan A, Awaisu A, Abd. Aziz N, Yahaya R and Salhani A (2009). Trend in the Use of Oral Hypoglycemic Agents in an Outpatient Pharmacy Department of a Tertiary Hospital in Malaysia. Asian Journal of Pharmaceutical and Clinical Research 2 (2): 40-46.
Scavini M, Stidley CA, Shah VO et al (2003). Prevalence of diabetes is higher among female than male Zuni Indians. Diabetes Care (26): 55-60.
Upadhyay DK, Palaian S, Ravi Shankar P, Mishra P, Sah AK (2007). Prescribing Pattern in Diabetic Outpatients in a Tertiary Care Teaching Hospital in Nepal. Journal of Clinical and Diagnostic Research. 1(4):248-255.
Good CB (2002). Polypharmacy in elderly patients with diabetes. Diabetes Spectrum 15(4): 240-248.
Okoro EO, Adejumo AO, Oyejola BA (2002). Diabetic Care in Nigeria: Report of a Self-audit. Journal of Diabetes Complications 16:15964.
Federal Ministry of Health. ESSENTIAL DRUG LIST, 2005.
Hassan Y, Mathialagan A, Awaisu A, Abd. Aziz N, Yahaya R and Salhani A (2009). Trend in the Use of Oral Hypoglycemic Agents in an Outpatient Pharmacy Department of a Tertiary Hospital in Malaysia. Asian Journal of Pharmaceutical and Clinical Research 2 (2): 40-46.
World Health Organization (1994). Management of Diabetes Mellitus-Standards of Care and Clinical Practice Guidelines. (Ed) Alwan, A.A.S. (WHOEM/DIN6/E/G).
Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R and Zinman B (2006). Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy, American Diabetes Association. Diabetes Care 29: 1963-1972.
Boccuzzi S.J, Wogen J, Fox J, Sung CY, Shah AB, Kim J (2001). Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population Diabetes Care 24: 14111415.
Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC and Holman RR (2000). Association of Systolic Blood Pressure with Macrovascular and Microvascular Complications of Type 2 Diabetes ( UKPD S36 ) : Prospective Observational Study. British Medical Journal 321:412- 419.
Arije A, Kuti M, Fasanmade A, Akinlade K, Ashaye A, Obajimi M, Adeleye, J (2007). Control of hypertension in Nigerians with Diabetes Mellitus: A report of the Ibadan Diabetic / Kidney Disease Study Group. International journal of Diabetes & Metabolism 15: 82-86. 64 West African Journal of Pharmacy (2012) 23 (2)
Arauz-Pacheco C, Parrott MA, Raskin P et al (2004). Hypertension Management in Adults with Diabetes. Diabetes Care 27: S 65-67.
Zimmerman BR (2000). Management to Decrease Cardiovascular Disease in Patients with Type 2 Diabetes. Medicina 60 (I): 15-17.
American Diabetes Association (2004). Hypertension Management in Adults with Diabetes. Diabetes Care 27(1): S65-S67.
Enwere OO, Salako BL, Falade CO (2006). Prescription and Cost Consideration at a Diabetic Clinic in Ibadan, Nigeria: A report. Annals of Ibadan Postgraduate Medicine 4 (2):35-39.
Joshi N, Caputo G, Weitekamp M, Karchmer AW(1999). Infections in patients with Diabetes Mellitus. New England Journal of Medicine 341:
Votey S R, Peters AL (2008). Diabetes Mellitus, Type 2 - A Review excerpt. from e Medicine Clinical reference, section 1-10